Committee Opinion No 544: Over-the-counter access to oral contraceptives.
Committee Opinion No 544: Over-the-counter access to oral contraceptives.
复制标题
DOI：
10.1097/01.aog.0000423818.85283.bd
复制
发表时间：
2012-12-01
影响因子：
7.2
通讯作者：
中科院分区：
文献类型：
--
作者：
意外怀孕仍然是美国的一个主要公共卫生问题。获取和成本问题是女性不使用避孕药具或使用差距的常见原因。改善避孕药具的获取和使用并可能降低意外怀孕率的一个潜在方法是允许非处方药获得口服避孕药 (OC)。从医学上来说，提供激素避孕不需要进行宫颈癌或性传播感染筛查。令人担忧的问题包括药剂师服务的费用、保险公司对非处方药的付款，以及药剂师不当拒绝提供药的可能性。根据当前可用数据权衡风险与收益，OC 应该可以通过非处方药购买。女性应使用检查表自我筛查 OC 的大多数禁忌症。
Unintended pregnancy remains a major public health problem in the United States. Access and cost issues are common reasons why women either do not use contraception or have gaps in use. A potential way to improve contraceptive access and use, and possibly decrease unintended pregnancy rates, is to allow over-the-counter access to oral contraceptives (OCs). Screening for cervical cancer or sexually transmitted infections is not medically required to provide hormonal contraception. Concerns include payment for pharmacist services, payment for over-the-counter OCs by insurers, and the possibility of pharmacists inappropriately refusing to provide OCs. Weighing the risks versus the benefits based on currently available data, OCs should be available over-the-counter. Women should self-screen for most contraindications to OCs using checklists.